Balance Sheet

v3.25.2

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2025	Dec. 31, 2024
CURRENT ASSETS
Cash	$ 59,172	$ 513,443
Prepaid expenses	12,341	65,300
Due from Chromocell Corporation	40,400	40,400
Deferred offering costs	710,937	750,000
TOTAL CURRENT ASSETS	822,850	1,369,143
TOTAL ASSETS	822,850	1,369,143
CURRENT LIABILITIES
Accounts payable and accrued expenses	4,988,822	1,897,127
Accrued compensation	23,636
Loan payable, net of debt discount	2,172,819	2,054,202
Loan payable - related party, net of debt discount	131,868	131,868
TOTAL CURRENT LIABILITIES	7,317,145	4,083,197
TOTAL LIABILITIES	7,317,145	4,083,197
STOCKHOLDERS’ DEFICIT
Common stock, $0.0001 par value, 200,000,000 shares authorized, 673,320 and 610,389 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	67	61
Additional paid in capital	20,397,175	18,760,872
Accumulated deficit	(26,891,537)	(21,474,987)
TOTAL STOCKHOLDERS’ DEFICIT	(6,494,295)	(2,714,054)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	822,850	1,369,143
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred stock, value, issued
Series C Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred stock, value, issued

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Source